Entry |
|
Symbol |
AKT3, MPPH, MPPH2, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2
|
Name |
(RefSeq) AKT serine/threonine kinase 3
|
KO |
|
Organism |
|
Pathway |
hsa01521 | EGFR tyrosine kinase inhibitor resistance |
hsa04072 | Phospholipase D signaling pathway |
hsa04213 | Longevity regulating pathway - multiple species |
hsa04261 | Adrenergic signaling in cardiomyocytes |
hsa04550 | Signaling pathways regulating pluripotency of stem cells |
hsa04613 | Neutrophil extracellular trap formation |
hsa04620 | Toll-like receptor signaling pathway |
hsa04625 | C-type lectin receptor signaling pathway |
hsa04660 | T cell receptor signaling pathway |
hsa04662 | B cell receptor signaling pathway |
hsa04664 | Fc epsilon RI signaling pathway |
hsa04666 | Fc gamma R-mediated phagocytosis |
hsa04810 | Regulation of actin cytoskeleton |
hsa04914 | Progesterone-mediated oocyte maturation |
hsa04919 | Thyroid hormone signaling pathway |
hsa04920 | Adipocytokine signaling pathway |
hsa04923 | Regulation of lipolysis in adipocytes |
hsa04932 | Non-alcoholic fatty liver disease |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications |
hsa04935 | Growth hormone synthesis, secretion and action |
hsa04973 | Carbohydrate digestion and absorption |
hsa05163 | Human cytomegalovirus infection |
hsa05166 | Human T-cell leukemia virus 1 infection |
hsa05167 | Kaposi sarcoma-associated herpesvirus infection |
hsa05168 | Herpes simplex virus 1 infection |
hsa05170 | Human immunodeficiency virus 1 infection |
hsa05207 | Chemical carcinogenesis - receptor activation |
hsa05208 | Chemical carcinogenesis - reactive oxygen species |
hsa05230 | Central carbon metabolism in cancer |
hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
hsa05418 | Fluid shear stress and atherosclerosis |
|
Network |
|
Element |
N00030 | EGF-EGFR-RAS-PI3K signaling pathway |
N00031 | Duplication or mutation-activated FLT3 to RAS-PI3K signaling pathway |
N00032 | Mutation-activated KRAS/NRAS to PI3K signaling pathway |
N00033 | EGF-EGFR-PI3K signaling pathway |
N00034 | ERBB2-overexpression to PI3K signaling pathway |
N00035 | Amplified EGFR to PI3K signaling pathway |
N00036 | Mutation-activated EGFR to PI3K signaling pathway |
N00037 | FGF-FGFR-PI3K signaling pathway |
N00038 | Amplified FGFR to PI3K signaling pathway |
N00039 | PDGF-PDGFR-PI3K signaling pathway |
N00040 | Amplified PDGFR to PI3K signaling pathway |
N00042 | EGFR-overexpression to PI3K signaling pathway |
N00043 | HGF-MET-PI3K signaling pathway |
N00044 | Mutation-activated MET to PI3K signaling pathway |
N00045 | KITLG-KIT-PI3K signaling pathway |
N00046 | Mutation-activated KIT to PI3K signaling pathway |
N00047 | EML4-ALK fusion kinase to PI3K signaling pathway |
N00048 | BCR-ABL fusion kinase to PI3K signaling pathway |
N00049 | Mutation-activated PI3K to PI3K signaling pathway |
N00050 | Amplified PI3K to PI3K signaling pathway |
N00051 | Deleted PTEN to PI3K signaling pathway |
N00052 | Mutation-inactivated PTEN to PI3K signaling pathway |
N00082 | Loss of NKX3-1 to PI3K signaling pathway |
N00154 | CXCR-GNB/G-PI3K-AKT signaling pathway |
N00182 | IGF-IGFR-PI3K-NFKB signaling pathway |
N00218 | FLT3LG-FLT3-RAS-PI3K signaling pathway |
N00220 | PTEN-PIP3-AKT signaling pathway |
N00231 | TGFA-EGFR-PI3K signaling pathway |
N00232 | TGFA-overexpression to PI3K signaling pathway |
N00234 | IGF2-IGF1R-PI3K signaling pathway |
N00236 | IGF2-overexpression to PI3K signaling pathway |
N00238 | IGF1R-overexpression to PI3K signaling pathway |
N00247 | HGF-overexpression to PI3K signaling pathway |
N00249 | MET-overexpression to PI3K signaling pathway |
N00253 | Amplified ERBB2 to PI3K signaling pathway |
N00260 | Amplified MET to PI3K signaling pathway |
N00281 | EGF-overexpression to PI3K signaling pathway |
N00282 | EREG-EGFR-PI3K signaling pathway |
N00283 | EREG-overexpression to PI3K signaling pathway |
N00284 | AREG-EGFR-PI3K signaling pathway |
N00285 | AREG-overexpression to PI3K signaling pathway |
N00342 | MAGI-PTEN signaling pathway |
N00355 | PP2A-AKT signaling pathway |
N00390 | EGF-EGFR-PI3K-NFKB signaling pathway |
N00399 | CCR2-GNB/G-PI3K-NFKB signaling pathway |
N00430 | CXCR4-GNAI-PI3K-BAD signaling pathway |
N00514 | Mutation-activated EGFR to PI3K signaling pathway |
N00582 | IGF-IGF1R-PI3K signaling pathway |
N00683 | CD80/CD86-CD28-PI3K signaling pathway |
N00963 | RELN-VLDLR-PI3K signaling pathway |
N00964 | DAB1-overexpression to RELN-VLDLR-PI3K signaling pathway |
N01063 | Mutation-activated MET to PI3K signaling pathway |
N01065 | Mutation-activated RET to PI3K signaling pathway |
N01163 | NRG-ERBB4-PI3K signaling pathway |
N01338 | ACH-CHRN-PI3K signaling pathway |
N01339 | NNK/NNN to PI3K signaling pathway |
N01347 | EP/NE-ADRB-PI3K signaling pathway |
N01348 | Nicotine/NNK to PI3K signaling pathway |
N01349 | ACH-CHRN-PI3K signaling pathway |
N01350 | NNK/NNN to PI3K signaling pathway |
N01355 | Arsenic to PI3K signaling pathway |
N01356 | Membrane-initiated progesterone signaling pathway |
N01357 | P4/MPA to membrane-initiated progesterone signaling pathway |
N01358 | P4-PR-PI3K signaling pathway |
N01359 | P4/MPA to PR-PI3K signaling pathway |
N01409 | Metals to PI3K signaling pathway |
N01579 | CD80/CD86-CTLA4-PP2A signaling pathway |
N01656 | GF-RTK-PI3K signaling pathway |
N01657 | GPCR-PI3K signaling pathway |
N01658 | GF-RTK-RAS-PI3K signaling pathway |
N01695 | BCR-BCAP/CD19-PI3K signaling pathway |
N01696 | ICOSLG/ICOS-PI3K signaling pathway |
N01833 | DRAXIN-MAP1B axon guidance signaling |
N01858 | EFNB1-MAPT axon guidance signaling |
|
Disease |
H01885 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome |
|
Drug target |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
10000 (AKT3)
04012 ErbB signaling pathway
10000 (AKT3)
04014 Ras signaling pathway
10000 (AKT3)
04015 Rap1 signaling pathway
10000 (AKT3)
04370 VEGF signaling pathway
10000 (AKT3)
04371 Apelin signaling pathway
10000 (AKT3)
04630 JAK-STAT signaling pathway
10000 (AKT3)
04668 TNF signaling pathway
10000 (AKT3)
04066 HIF-1 signaling pathway
10000 (AKT3)
04068 FoxO signaling pathway
10000 (AKT3)
04072 Phospholipase D signaling pathway
10000 (AKT3)
04071 Sphingolipid signaling pathway
10000 (AKT3)
04024 cAMP signaling pathway
10000 (AKT3)
04022 cGMP-PKG signaling pathway
10000 (AKT3)
04151 PI3K-Akt signaling pathway
10000 (AKT3)
04152 AMPK signaling pathway
10000 (AKT3)
04150 mTOR signaling pathway
10000 (AKT3)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
10000 (AKT3)
09143 Cell growth and death
04210 Apoptosis
10000 (AKT3)
04218 Cellular senescence
10000 (AKT3)
09144 Cellular community - eukaryotes
04510 Focal adhesion
10000 (AKT3)
04550 Signaling pathways regulating pluripotency of stem cells
10000 (AKT3)
09142 Cell motility
04810 Regulation of actin cytoskeleton
10000 (AKT3)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
10000 (AKT3)
04613 Neutrophil extracellular trap formation
10000 (AKT3)
04620 Toll-like receptor signaling pathway
10000 (AKT3)
04625 C-type lectin receptor signaling pathway
10000 (AKT3)
04660 T cell receptor signaling pathway
10000 (AKT3)
04662 B cell receptor signaling pathway
10000 (AKT3)
04664 Fc epsilon RI signaling pathway
10000 (AKT3)
04666 Fc gamma R-mediated phagocytosis
10000 (AKT3)
04062 Chemokine signaling pathway
10000 (AKT3)
09152 Endocrine system
04910 Insulin signaling pathway
10000 (AKT3)
04922 Glucagon signaling pathway
10000 (AKT3)
04923 Regulation of lipolysis in adipocytes
10000 (AKT3)
04920 Adipocytokine signaling pathway
10000 (AKT3)
04929 GnRH secretion
10000 (AKT3)
04915 Estrogen signaling pathway
10000 (AKT3)
04914 Progesterone-mediated oocyte maturation
10000 (AKT3)
04917 Prolactin signaling pathway
10000 (AKT3)
04926 Relaxin signaling pathway
10000 (AKT3)
04935 Growth hormone synthesis, secretion and action
10000 (AKT3)
04919 Thyroid hormone signaling pathway
10000 (AKT3)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
10000 (AKT3)
09154 Digestive system
04973 Carbohydrate digestion and absorption
10000 (AKT3)
09156 Nervous system
04725 Cholinergic synapse
10000 (AKT3)
04728 Dopaminergic synapse
10000 (AKT3)
04722 Neurotrophin signaling pathway
10000 (AKT3)
09158 Development and regeneration
04380 Osteoclast differentiation
10000 (AKT3)
09149 Aging
04211 Longevity regulating pathway
10000 (AKT3)
04213 Longevity regulating pathway - multiple species
10000 (AKT3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
10000 (AKT3)
05205 Proteoglycans in cancer
10000 (AKT3)
05207 Chemical carcinogenesis - receptor activation
10000 (AKT3)
05208 Chemical carcinogenesis - reactive oxygen species
10000 (AKT3)
05230 Central carbon metabolism in cancer
10000 (AKT3)
05231 Choline metabolism in cancer
10000 (AKT3)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
10000 (AKT3)
09162 Cancer: specific types
05210 Colorectal cancer
10000 (AKT3)
05212 Pancreatic cancer
10000 (AKT3)
05225 Hepatocellular carcinoma
10000 (AKT3)
05226 Gastric cancer
10000 (AKT3)
05214 Glioma
10000 (AKT3)
05221 Acute myeloid leukemia
10000 (AKT3)
05220 Chronic myeloid leukemia
10000 (AKT3)
05218 Melanoma
10000 (AKT3)
05211 Renal cell carcinoma
10000 (AKT3)
05215 Prostate cancer
10000 (AKT3)
05213 Endometrial cancer
10000 (AKT3)
05224 Breast cancer
10000 (AKT3)
05222 Small cell lung cancer
10000 (AKT3)
05223 Non-small cell lung cancer
10000 (AKT3)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
10000 (AKT3)
05170 Human immunodeficiency virus 1 infection
10000 (AKT3)
05161 Hepatitis B
10000 (AKT3)
05160 Hepatitis C
10000 (AKT3)
05164 Influenza A
10000 (AKT3)
05162 Measles
10000 (AKT3)
05168 Herpes simplex virus 1 infection
10000 (AKT3)
05163 Human cytomegalovirus infection
10000 (AKT3)
05167 Kaposi sarcoma-associated herpesvirus infection
10000 (AKT3)
05169 Epstein-Barr virus infection
10000 (AKT3)
05165 Human papillomavirus infection
10000 (AKT3)
09171 Infectious disease: bacterial
05132 Salmonella infection
10000 (AKT3)
05131 Shigellosis
10000 (AKT3)
05135 Yersinia infection
10000 (AKT3)
05152 Tuberculosis
10000 (AKT3)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
10000 (AKT3)
05142 Chagas disease
10000 (AKT3)
09164 Neurodegenerative disease
05010 Alzheimer disease
10000 (AKT3)
05017 Spinocerebellar ataxia
10000 (AKT3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
10000 (AKT3)
05418 Fluid shear stress and atherosclerosis
10000 (AKT3)
05415 Diabetic cardiomyopathy
10000 (AKT3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
10000 (AKT3)
04932 Non-alcoholic fatty liver disease
10000 (AKT3)
04931 Insulin resistance
10000 (AKT3)
04933 AGE-RAGE signaling pathway in diabetic complications
10000 (AKT3)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
10000 (AKT3)
01524 Platinum drug resistance
10000 (AKT3)
01522 Endocrine resistance
10000 (AKT3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:hsa01001]
10000 (AKT3)
Enzymes [BR:hsa01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.1 non-specific serine/threonine protein kinase
10000 (AKT3)
Protein kinases [BR:hsa01001]
Serine/threonine kinases: AGC group
AKT/PKB family
10000 (AKT3)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
LinkDB |
|
Position |
1:complement(243488233..243851079)
|
AA seq |
479 aa
MSDVTIVKEGWVQKRGEYIKNWRPRYFLLKTDGSFIGYKEKPQDVDLPYPLNNFSVAKCQ
LMKTERPKPNTFIIRCLQWTTVIERTFHVDTPEEREEWTEAIQAVADRLQRQEEERMNCS
PTSQIDNIGEEEMDASTTHHKRKTMNDFDYLKLLGKGTFGKVILVREKASGKYYAMKILK
KEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE
RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA
ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM
EDIKFPRTLSSDAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFSGVNWQDVYDKKLVP
PFKPQVTSETDTRYFDEEFTAQTITITPPEKYDEDGMDCMDNERRPHFPQFSYSASGRE |
NT seq |
1440 nt +upstreamnt +downstreamnt
atgagcgatgttaccattgtgaaagaaggttgggttcagaagaggggagaatatataaaa
aactggaggccaagatacttccttttgaagacagatggctcattcataggatataaagag
aaacctcaagatgtggatttaccttatcccctcaacaacttttcagtggcaaaatgccag
ttaatgaaaacagaacgaccaaagccaaacacatttataatcagatgtctccagtggact
actgttatagagagaacatttcatgtagatactccagaggaaagggaagaatggacagaa
gctatccaggctgtagcagacagactgcagaggcaagaagaggagagaatgaattgtagt
ccaacttcacaaattgataatataggagaggaagagatggatgcctctacaacccatcat
aaaagaaagacaatgaatgattttgactatttgaaactactaggtaaaggcacttttggg
aaagttattttggttcgagagaaggcaagtggaaaatactatgctatgaagattctgaag
aaagaagtcattattgcaaaggatgaagtggcacacactctaactgaaagcagagtatta
aagaacactagacatccctttttaacatccttgaaatattccttccagacaaaagaccgt
ttgtgttttgtgatggaatatgttaatgggggcgagctgtttttccatttgtcgagagag
cgggtgttctctgaggaccgcacacgtttctatggtgcagaaattgtctctgccttggac
tatctacattccggaaagattgtgtaccgtgatctcaagttggagaatctaatgctggac
aaagatggccacataaaaattacagattttggactttgcaaagaagggatcacagatgca
gccaccatgaagacattctgtggcactccagaatatctggcaccagaggtgttagaagat
aatgactatggccgagcagtagactggtggggcctaggggttgtcatgtatgaaatgatg
tgtgggaggttacctttctacaaccaggaccatgagaaactttttgaattaatattaatg
gaagacattaaatttcctcgaacactctcttcagatgcaaaatcattgctttcagggctc
ttgataaaggatccaaataaacgccttggtggaggaccagatgatgcaaaagaaattatg
agacacagtttcttctctggagtaaactggcaagatgtatatgataaaaagcttgtacct
ccttttaaacctcaagtaacatctgagacagatactagatattttgatgaagaatttaca
gctcagactattacaataacaccacctgaaaaatatgatgaggatggtatggactgcatg
gacaatgagaggcggccgcatttccctcaattttcctactctgcaagtggacgagaataa |